Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

67%

4 trials in Phase 3/4

Results Transparency

80%

4 of 5 completed trials have results

Key Signals

1 recruiting4 with results

Enrollment Performance

Analytics

Phase 4

3(50.0%)

Phase 3

1(16.7%)

N/A

1(16.7%)

Phase 2

1(16.7%)

6Total

Phase 4(3)

Phase 3(1)

N/A(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07059091Phase 2Recruiting

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

Role: collaborator

NCT01629823Not ApplicableCompleted

Effect of Positive Airway Pressure on Reducing Airway Reactivity in Patients With Asthma (CPAP)

Role: lead

NCT01052116Phase 4Completed

The Study of Soy Isoflavones in Asthma

Role: lead

NCT00069823Phase 3Completed

Study of Acid Reflux in Asthma

Role: collaborator

NCT00442013Phase 4Completed

Lansoprazole to Treat Children With Asthma

Role: collaborator

NCT00148408Phase 4Completed

Trial of Asthma Patient Education (TAPE)

Role: lead

All 6 trials loaded